Abstract: A digital biosensor for assaying a target nucleic acid and methods of using the biosensor for digitally detecting the target nucleic acid are disclosed wherein the biosensor includes a substrate having a substrate surface and at least two electrodes, a linker molecule having a first moiety conjugated to the substrate surface, a ribonucleoprotein (RNP) conjugated to a second moiety of the linker molecule, and a guide ribonucleic acid (gRNA) having a first sequence capable of binding to the inactive RNP and a second sequence capable of binding to the target nucleic acid.
Type:
Grant
Filed:
August 6, 2018
Date of Patent:
February 20, 2024
Assignees:
KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Abstract: An airlift bioreactor for perfusion cell culture comprises a single- or multi-tiered riser for working volume scale-up, an internal inclined gravity settler for cell retention, an outlet port for cell-free spent culture medium removal, and an inlet port for fresh medium addition.
Type:
Grant
Filed:
March 20, 2019
Date of Patent:
September 6, 2022
Assignee:
KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES
Abstract: In accordance with the invention, isolated nucleic acids, expression methods, host cells, expression vectors, and DNA constructs for producing proteins, and proteins produced using the expression methods are described. More particularly, nucleic acids isolated from Pichia pastoris wherein the nucleic acids have promoter activity are described. The invention also relates to expression methods, host cells, expression vectors, and DNA constructs, for using the Pichia pastoris promoters to produce proteins, and to the proteins produced using the expression methods.
Type:
Grant
Filed:
March 7, 2014
Date of Patent:
April 14, 2020
Assignee:
Keck Graduate Institute of Applied Life Sciences
Abstract: Compositions and methods including Bithionol are provided for treating, inhibiting, or preventing caspase-dependent pathogenic agents in a host cell or infected subject. Examples of caspase-dependent pathogenic agents include ricin, anthrax toxin, Botulinum neurotoxin A, diphtheria toxin, Pseudomonas aeruginosa exotoxin A, cholera toxin, Zika virus, and combinations thereof. Compositions and methods also include Bithionol in combination with an antibiotic for more effective clearance of the pathogen and/or toxins.
Type:
Grant
Filed:
October 21, 2016
Date of Patent:
August 6, 2019
Assignee:
Keck Graduate Institute of Applied Life Sciences
Abstract: Compositions and methods including Amodiaquine (AQ) or N-Desethy Amodiaquine (DEAQ) are provided for treating, inhibiting, or preventing cathepsin B dependent pathogens and toxins in a host cell or infected subject. Compositions and methods also include AQ or DEAQ in combination with an antibiotic for more effective clearance of the pathogen and/or toxins.
Type:
Grant
Filed:
October 23, 2015
Date of Patent:
August 7, 2018
Assignee:
Keck Graduate Institute of Applied Life Sciences
Inventors:
Mikhail Martchenko, Leeor Zilbermintz, William Leonardi
Abstract: A disposable and inexpensive biological diagnostic cartridge for the amplification and detection of nucleic acids includes a configuration having a reaction pouch for amplification which is compressed by a flexible pump pouch for detection of the amplified reaction.
Type:
Grant
Filed:
April 10, 2013
Date of Patent:
October 24, 2017
Assignee:
Keck Graduate Institute of Applied Life Sciences
Inventors:
Angelika Niemz, Anna Hickerson, Kristina Roskos, Hsiang-Wei Lu
Abstract: Methods of inhibiting or preventing the proliferation of a fungus and/or a bacteria in a living organism, in water, in air, and/or on surfaces, include administering or providing a therapeutic amount or an effective amount of an antimicrobial composition including Octodrine.
Type:
Grant
Filed:
January 13, 2014
Date of Patent:
September 13, 2016
Assignee:
KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES
Abstract: Methods of inhibiting or preventing the proliferation of a fungus and/or a bacteria in a living organism, in water, in air, and/or on surfaces, include administering or providing a therapeutic amount or an effective amount of an antimicrobial composition including Octodrine.
Type:
Application
Filed:
January 13, 2014
Publication date:
July 16, 2015
Applicant:
KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES
Abstract: The present invention provides human tyrosine-DNA phosphodiesterases (TDPs). In particular, the present invention provides novel recombinant nucleic acids and proteins, including mutant TDPs, vectors, and TDP-producing cells, as well as co-factors for enzyme activity. The present invention further provides methods for high through-put enzymatic assay systems utilizing the TDPs of the present invention.
Type:
Application
Filed:
October 4, 2002
Publication date:
July 3, 2003
Applicant:
Keck Graduate Institute Of Applied Life Sciences